Browse Category

Investment Insights News 15 December 2025 - 16 December 2025

Intuitive Surgical (ISRG) Stock After Hours: What Happened on Dec. 15, 2025—and What to Watch Before Tuesday’s Open

Intuitive Surgical (ISRG) Stock After Hours: What Happened on Dec. 15, 2025—and What to Watch Before Tuesday’s Open

Intuitive Surgical, Inc. (NASDAQ: ISRG) ended Monday’s session (December 15, 2025) with a notable rebound—then slipped modestly in after-hours trading. For investors watching the robotic surgery leader into Tuesday’s open (December 16, 2025), the setup is a mix of stock-specific
SoFi Technologies Stock After Hours (Dec. 15, 2025): Why SOFI Dropped, Fresh Headlines, Analyst Forecasts, and What to Watch Before Tuesday’s Open

SoFi Technologies Stock After Hours (Dec. 15, 2025): Why SOFI Dropped, Fresh Headlines, Analyst Forecasts, and What to Watch Before Tuesday’s Open

SoFi Technologies, Inc. (NASDAQ: SOFI) ended Monday, December 15, 2025, sharply lower, and the stock stayed active in extended trading after the closing bell. SOFI finished the regular session around $25.81–$25.82 (down about 5.35%–5.4%) and traded around $25.71 in late
Salesforce (CRM) Stock After Hours Today (Dec. 15, 2025): Why Shares Fell, What’s Moving the AI Thesis, and What to Watch Before Tuesday’s Open

Salesforce (CRM) Stock After Hours Today (Dec. 15, 2025): Why Shares Fell, What’s Moving the AI Thesis, and What to Watch Before Tuesday’s Open

Salesforce, Inc. (NYSE: CRM) ended Monday’s session under pressure and stayed soft in extended trading. CRM closed at $254.58, down 2.92%, and was $253.50 in after-hours trading as of 5:59 p.m. ET (down another 0.42% from the close). StockAnalysis That
Circle Internet Group, Inc. (CRCL) Stock Today: Latest News, Price Move, and Wall Street Forecasts (Dec. 15, 2025)

Circle Internet Group, Inc. (CRCL) Stock Today: Latest News, Price Move, and Wall Street Forecasts (Dec. 15, 2025)

Circle Internet Group, Inc. (NYSE: CRCL) is back in the spotlight on December 15, 2025, as investors weigh a fresh technology push, an expanding regulatory footprint, and intensifying debate over how stablecoin issuers should be supervised inside the U.S. financial
Coherent Corp. (COHR) Stock: JPMorgan Raises Target to $215 as AI Data-Center Catalysts Drive Fresh Focus (Dec. 15, 2025)

Coherent Corp. (COHR) Stock: JPMorgan Raises Target to $215 as AI Data-Center Catalysts Drive Fresh Focus (Dec. 15, 2025)

As of Monday, December 15, 2025, Coherent Corp. (NYSE: COHR) is back in the spotlight after a new wave of analyst commentary and product momentum rekindled investor interest in the photonics and advanced materials name. The stock traded around $180
CECO Environmental Corp Stock News Today (NASDAQ: CECO): Record $135M Order, $1B Bookings Outlook, and What Analysts Forecast Next

CECO Environmental Corp Stock News Today (NASDAQ: CECO): Record $135M Order, $1B Bookings Outlook, and What Analysts Forecast Next

CECO Environmental Corp. (Nasdaq: CECO) is in the spotlight on December 15, 2025, after the company announced its largest order ever—exceeding $135 million—for an emissions management solution tied to a Texas-based natural gas power generation facility supporting data center expansion.
Corebridge Financial (CRBG) Stock Jumps Ahead of S&P MidCap 400 Addition: Latest News, Dividend, and Analyst Forecasts (Dec. 15, 2025)

Corebridge Financial (CRBG) Stock Jumps Ahead of S&P MidCap 400 Addition: Latest News, Dividend, and Analyst Forecasts (Dec. 15, 2025)

Corebridge Financial, Inc. (NYSE: CRBG) is getting a very specific kind of attention on December 15, 2025: the “index inclusion + dividend setup” cocktail that tends to light up screens, drive short-term flows, and trigger a lot of fast-twitch trading.
Immunome (IMNM) Stock Surges After Positive Phase 3 Varegacestat Data: Latest News, Analyst Forecasts, and What Comes Next (Dec. 15, 2025)

Immunome (IMNM) Stock Surges After Positive Phase 3 Varegacestat Data: Latest News, Analyst Forecasts, and What Comes Next (Dec. 15, 2025)

December 15, 2025 — Immunome, Inc. (NASDAQ: IMNM) is having the kind of biotech day that traders circle in red ink: a major clinical trial win, a sharp move in the share price, and a fast-rising debate over what “best-in-class”
Ford Motor Company Stock (NYSE: F) News Today: Key Headlines, Analyst Forecasts, and What’s Driving Ford Shares on Dec. 15, 2025

Ford Motor Company Stock (NYSE: F) News Today: Key Headlines, Analyst Forecasts, and What’s Driving Ford Shares on Dec. 15, 2025

Ford Motor Company stock (NYSE: F) is starting the week in focus as investors weigh a fresh batch of policy signals, EV demand crosscurrents, and a growing list of “pragmatic” strategic moves—especially in Europe. In early indications on Monday, Dec.
Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals (MIST) Stock: FDA Approval of CARDAMYST, Launch Timeline, and Analyst Forecasts (Dec. 15, 2025)

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) entered a new phase in its corporate life this month: from clinical-stage story stock to a company with an FDA-approved, commercially launchable cardiovascular product. The catalyst is CARDAMYST™ (etripamil) nasal spray, now approved in the
1 13 14 15 16 17 44
Go toTop